410 related articles for article (PubMed ID: 21356072)
1. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
Trials; 2011 Feb; 12():58. PubMed ID: 21356072
[TBL] [Abstract][Full Text] [Related]
2. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
Abraha I; Cherubini A; Cozzolino F; De Florio R; Luchetta ML; Rimland JM; Folletti I; Marchesi M; Germani A; Orso M; Eusebi P; Montedori A
BMJ; 2015 May; 350():h2445. PubMed ID: 26016488
[TBL] [Abstract][Full Text] [Related]
3. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
Beckett RD; Loeser KC; Bowman KR; Towne TG
BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
[TBL] [Abstract][Full Text] [Related]
4. A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews.
Abraha I; Cozzolino F; Orso M; Marchesi M; Germani A; Lombardo G; Eusebi P; De Florio R; Luchetta ML; Iorio A; Montedori A
J Clin Epidemiol; 2017 Apr; 84():37-46. PubMed ID: 28088592
[TBL] [Abstract][Full Text] [Related]
5. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
6. Impact of industry collaboration on randomised controlled trials in oncology.
Linker A; Yang A; Roper N; Whitaker E; Korenstein D
Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518
[TBL] [Abstract][Full Text] [Related]
7. Industry sponsorship and research outcome.
Lundh A; Lexchin J; Mintzes B; Schroll JB; Bero L
Cochrane Database Syst Rev; 2017 Feb; 2(2):MR000033. PubMed ID: 28207928
[TBL] [Abstract][Full Text] [Related]
8. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression.
Froud R; Bjørkli T; Bright P; Rajendran D; Buchbinder R; Underwood M; Evans D; Eldridge S
BMC Musculoskelet Disord; 2015 Nov; 16():370. PubMed ID: 26620449
[TBL] [Abstract][Full Text] [Related]
9. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.
Clifford TJ; Barrowman NJ; Moher D
BMC Health Serv Res; 2002 Sep; 2(1):18. PubMed ID: 12213183
[TBL] [Abstract][Full Text] [Related]
10. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
Grey P; Grey A; Bolland MJ
Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
[TBL] [Abstract][Full Text] [Related]
11. Modified intention-to-treat analysis did not bias trial results.
Dossing A; Tarp S; Furst DE; Gluud C; Wells GA; Beyene J; Hansen BB; Bliddal H; Christensen R
J Clin Epidemiol; 2016 Apr; 72():66-74. PubMed ID: 26562052
[TBL] [Abstract][Full Text] [Related]
12. Methodological reporting of randomized clinical trials in respiratory research in 2010.
Lu Y; Yao Q; Gu J; Shen C
Respir Care; 2013 Sep; 58(9):1546-51. PubMed ID: 23307824
[TBL] [Abstract][Full Text] [Related]
13. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
[TBL] [Abstract][Full Text] [Related]
14. Industry sponsorship and research outcome.
Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
[TBL] [Abstract][Full Text] [Related]
15. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews.
He J; Du L; Liu G; Fu J; He X; Yu J; Shang L
Trials; 2011 May; 12():122. PubMed ID: 21569452
[TBL] [Abstract][Full Text] [Related]
16. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
Falk Delgado A; Falk Delgado A
Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
[TBL] [Abstract][Full Text] [Related]
17. A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndrome.
Chen B; Liu J; Zhang C; Li M
Trials; 2014 Apr; 15():128. PubMed ID: 24746168
[TBL] [Abstract][Full Text] [Related]
18. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
19. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
Gravel J; Opatrny L; Shapiro S
Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
Bero L; Oostvogel F; Bacchetti P; Lee K
PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
